Nanoviricides (NNVC) Operating Expenses (2010 - 2026)
Nanoviricides (NNVC) recorded Operating Expenses of $2.25 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), up 6.2% from $2.12 million a year earlier and up 10.6% from the prior quarter.
Nanoviricides (NNVC) Operating Expenses (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Nanoviricides reported Operating Expenses of $8.31 million, down 13.4% from FY2025.
- Annual Operating Expenses has a five-year compound annual growth rate of -1.0% (FY2021 to FY2026).
- Across earlier fiscal years, Operating Expenses came in at $9.59 million in FY2025 (+12.6%), $8.52 million in FY2024 (-4.8%), $8.94 million in FY2023 (+10.2%) and $8.11 million in FY2022 (-7.2%).
- The fiscal Q4 2026 figure is the highest quarterly Operating Expenses since fiscal Q3 2025.
- On a year-over-year basis, Operating Expenses rose in four of the last eight quarters, with growth averaging 2.3%.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 105.1% in fiscal Q4 2023, against a decline of 43.3% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $2.03 million (Q3 2026), $2.23 million (Q2 2026) and $1.8 million (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 7.95 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 10.12 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 10.56 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 12.80 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 6.09 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 9.70 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 6.54 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 18.20 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 6.68 Bn |
| 10 | Nanoviricides | 30.08 Mn | 17.74 Mn | - | 2.25 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.25 Mn |
| Mar 31, 2026 | 2.03 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Mar 31, 2025 | 2.25 Mn |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 2.18 Mn |
| Sep 30, 2023 | 2.03 Mn |
| Jun 30, 2023 | 3.68 Mn |
| Mar 31, 2023 | 1.81 Mn |
| Dec 31, 2022 | 1.83 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 1.79 Mn |
| Dec 31, 2021 | 1.92 Mn |
| Sep 30, 2021 | 2.61 Mn |
Nanoviricides Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "NNVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=NNVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();